Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thrombolysis in Ischemic Spinal Cord Stroke

NCT02242084 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT02242084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02242084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thrombolysis in Ischemic Spinal Cord Stroke
Lead sponsor
Rabin Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2016
Completion date
March 26, 2019
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

damage in the anterior spinal artery (asa), motor weakness in two or four limbs, temperature and superficial sensation, urinary retention or bowel disorder